The COVID-19 pandemic has shown how quickly biotech companies can innovate and deploy solutions to combat diseases, says Noubar Afeyan, co-founder of vaccine maker Moderna. The entrepreneur, who is also the founder and CEO of life sciences venture firm Flagship Pioneering, shares his thoughts on CNA’s Asia Now.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service for must-read stories:
Telegram – https://cna.asia/telegram
WhatsApp – https://cna.asia/whatsapp

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
TikTok: https://www.tiktok.com/@channelnewsasia